Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic

R Bhandari, G Khanna, A Kuhad - European Journal of Pharmacology, 2021 - Elsevier
Coronaviruses are pleomorphic, enveloped, or spherical viruses, which have a size ranging
from 80 to 120 nm. These viruses act on receptors that cause the triggering of fusion …

An overview on anti-COVID-19 drug achievements and challenges ahead

M Valipour, H Irannejad, H Keyvani - ACS Pharmacology & …, 2023 - ACS Publications
The appearance of several coronavirus pandemics/epidemics during the last two decades
(SARS-CoV-1 in 2002, MERS-CoV in 2012, and SARS-CoV-2 in 2019) indicates that …

Pathophysiology and potential therapeutic candidates for COVID-19: a poorly understood arena

A Samaddar, M Grover, VL Nag - Frontiers in pharmacology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), an acute onset pneumonia caused by a novel
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …

An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …

SARS-CoV-2: repurposed drugs and novel therapeutic approaches—insights into chemical structure—biological activity and toxicological screening

CA Dehelean, V Lazureanu, D Coricovac… - Journal of clinical …, 2020 - mdpi.com
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic represents the
primary public health concern nowadays, and great efforts are made worldwide for efficient …

An up-to-date overview of therapeutic agents for the treatment of COVID-19 disease

T Mulaw Belete - Clinical pharmacology: advances and …, 2020 - Taylor & Francis
Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a great potential to
overwhelm the world healthcare systems that may lead to high morbidity and mortality. It …

Current scenario and future prospect in the management of COVID-19

P Borah, PK Deb, S Deka… - Current Medicinal …, 2021 - ingentaconnect.com
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …

A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29

SPH Alexander, JF Armstrong… - British journal of …, 2020 - Wiley Online Library
In this review, we identify opportunities for drug discovery in the treatment of COVID‐19 and,
in so doing, provide a rational roadmap whereby pharmacology and pharmacologists can …

[HTML][HTML] Emerging pharmaceutical treatments of novel COVID-19: a review

A Hussain, J Kaler, AK Dubey - Cureus, 2020 - ncbi.nlm.nih.gov
As a new decade began, COVID-19 quickly gained importance as it became the cause of
the current global pandemic. Research has been focusing on studying the structure of SARS …

Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years

G Remuzzi, S Schiaffino, MG Santoro… - Frontiers in …, 2022 - frontiersin.org
The COVID-19 Committee of the Lincei Academy has reviewed the scientific evidence
supporting the efficacy and safety of existing and new drugs/biologics for the preventing and …